R Squared’s Caribou Biosciences CRBU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.4K Buy
+17,648
New +$27.6K 0.01% 489
2025
Q4
– Sell
-12,268
Closed -$28.6K – 561
2025
Q3
$28.6K Buy
+12,268
New +$23.2K 0.01% 521

Other funds holding CRBU

R Squared's CRBU Position: Q3 2026 in Review

R Squared opened a new position in Caribou Biosciences (CRBU) in Q3 2026: 17,648 shares worth $22.4K. The stake represents 0.01% of the portfolio and ranks #489 among its holdings. This is a return to the name: R Squared previously reported a position in CRBU as recently as Q3 2025.

R Squared first reported a position in CRBU in Q3 2025 and has held it in 2 quarters since. The position peaked at $28.6K in Q3 2025. 147 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.

  • R Squared held 17,648 shares of Caribou Biosciences worth $22.4K as of Q3 2026.
  • Caribou Biosciences was a new R Squared position in Q3 2026.
  • Caribou Biosciences made up 0.01% of R Squared's portfolio in Q3 2026, its #489 holding.
  • R Squared first reported a position in Caribou Biosciences in Q3 2025 and has held it in 2 quarters since.
  • R Squared's Caribou Biosciences position peaked at $28.6K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.

Based on R Squared's 13F filing for Q3 2026, filed 6 Nov 2026.